Qin J et al. |
GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis. |
2017 |
J. Neurosci. |
pmid:28899916
|
Ruggiero FM et al. |
Membrane binding, endocytic trafficking and intracellular fate of high-affinity antibodies to gangliosides GD1a and GM1. |
2017 |
Biochim. Biophys. Acta |
pmid:27806911
|
Ji S et al. |
Increased a-series gangliosides positively regulate leptin/Ob receptor-mediated signals in hypothalamus of GD3 synthase-deficient mice. |
2016 |
Biochem. Biophys. Res. Commun. |
pmid:27644882
|
Kim DS et al. |
Porcine Sapelovirus Uses α2,3-Linked Sialic Acid on GD1a Ganglioside as a Receptor. |
2016 |
J. Virol. |
pmid:26865725
|
Heredia V et al. |
Interfacial stabilization of the antitumoral drug Paclitaxel in monolayers of GM1 and GD1a gangliosides. |
2015 |
Biochim. Biophys. Acta |
pmid:26119566
|
Koga M et al. |
Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies. |
2015 |
PLoS ONE |
pmid:25867522
|
Wang Y et al. |
Ganglioside GD1a suppresses LPS-induced pro-inflammatory cytokines in RAW264.7 macrophages by reducing MAPKs and NF-κB signaling pathways through TLR4. |
2015 |
Int. Immunopharmacol. |
pmid:26054879
|
Miklavcic JJ et al. |
Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. |
2015 |
World J. Gastroenterol. |
pmid:26401073
|
Tsukamoto K et al. |
CRISPR/Cas9-Mediated Genomic Deletion of the Beta-1, 4 N-acetylgalactosaminyltransferase 1 Gene in Murine P19 Embryonal Carcinoma Cells Results in Low Sensitivity to Botulinum Neurotoxin Type C. |
2015 |
PLoS ONE |
pmid:26177297
|
Xu X et al. |
A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis. |
2015 |
Dis Model Mech |
pmid:26035393
|
Zheng Y et al. |
Efficient biotransformation of polysialogangliosides for preparation of GM1 by Cellulosimicrobium sp. 21. |
2014 |
Molecules |
pmid:25299818
|
Morgan ML et al. |
Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome. |
2014 |
J Neuroophthalmol |
pmid:25062498
|
Bergante S et al. |
Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow mesenchymal stem cells. |
2014 |
J. Lipid Res. |
pmid:24449473
|
Vachalová I et al. |
Anti-GM2, -GD1a and -GD1b positive purely isolated facial diplegia. |
2014 |
Clin Neurol Neurosurg |
pmid:24813327
|
Berntsson RP et al. |
Structure of dual receptor binding to botulinum neurotoxin B. |
2013 |
Nat Commun |
pmid:23807078
|
Uncini A et al. |
Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies. |
2013 |
Muscle Nerve |
pmid:23625341
|
Wakerley BR et al. |
Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia. |
2013 |
J. Neurol. Neurosurg. Psychiatry |
pmid:23564757
|
Kim SY et al. |
Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome. |
2013 |
J Clin Neurosci |
pmid:23164827
|
Ogawa G et al. |
An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure. |
2013 |
J. Neuroimmunol. |
pmid:23000056
|
Lee HC et al. |
Ganglioside inhibition of CD8+ T cell cytotoxicity: interference with lytic granule trafficking and exocytosis. |
2012 |
J. Immunol. |
pmid:22956583
|